Oncotype DX Breast Cancer Recurrence Score Resists Inter-Assay Reproducibility With RT2-Profiler Multiplex RT-PCR

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-56910-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oncotype Dx Recurrence Score Among BRCA1/2 Germline Mutation Carriers With Hormone Receptors Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Treatment Decisions in Estrogen Receptor-Positive Early Breast Cancer Patients With Intermediate Oncotype DX Recurrence Score Results

SpringerPlus
Multidisciplinary
2014English

The ZNF217 Biomarker Predicts Low- And High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers

Frontiers in Pharmacology
Pharmacology
2019English

The Impact of Oncotype DX® Recurrence Score of Paraffin-Embedded Core Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in Women With Breast Cancer

Breast Disease
MedicineCancer ResearchOncology
2016English

Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Examination of the Biomark Assay as an Alternative to Oncotype DX for Defining Chemotherapy Benefit

Oncology Letters
Cancer ResearchOncology
2018English

Community Clinical Practice Patterns and Mortality in Patients With Intermediate Oncotype DX Recurrence Scores: Who Benefits From Chemotherapy?

Cancer
Cancer ResearchOncology
2018English

Evaluation and Correlation of Risk Recurrence in Early Breast Cancer Assessed by Oncotype DX®, Clinicopathological Markers and Tumor Cell Dissemination in the Blood and Bone Marrow

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy